top of page
Browse by category
Search
Johnson & Johnson MedTech launches the ETHICON 4000 Stapler
Johnson & Johnson MedTech has launched the ETHICON 4000 Stapler, an advanced surgical stapler designed to manage tissue complexities and...
Semaglutide associated with double risk of neovascular macular degeneration
Semaglutide is associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older...
Johnson & Johnson MedTech launches the DUALTO Energy System combining multiple energy modalities into an integrated platform for use across open and minimally invasive surgery
Johnson & Johnson MedTech has launched the DUALTO Energy System, a surgical solution that combines multiple energy modalities into an...
Leading societies endorse Treat and Reduce Obesity Act
The Endocrine Society and the National Council on Aging (NCOA) have endorsed the introduction of the bipartisan Treat and Reduce Obesity...
Weight stigma, not weight, has the biggest effect on mental health after BMS
Weight stigma - and not weight itself - has the biggest impact on mental health and healthy behaviours in the years after bariatric and...
Society of Obesity and Bariatric Anaesthesia publishes 43 recommendations to improve the safety and efficacy of airway management in patients living with obesity
The UK’s Society of Obesity and Bariatric Anaesthesia (SOBA) has published 43 recommendations which cover a number of key areas of...
MHRA urges women using GLP-1s to use effective contraception
Medicines and Healthcare products Regulatory Agency (MHRA) urges women who are taking GLP-1 medicines for weight loss and diabetes - such...
Maternal obesity linked to child's heightened hospital admission risk for infection
Children who are born to mothers who are living with severe obesity (BMI of 35 or higher) are at heightened risk of being admitted to...
Combination of weight loss drugs better for pre-BMS patients than GLP-1s or dieting alone
A study by Pennington Biomedical Research Center's Metamor Institute researchers that evaluated the use of different types of pre-surgery...
COURAGE Trial confirms potential to improve the quality of semaglutide-induced weight loss by preserving lean mass
Interim results from the ongoing Phase 2 COURAGE trial - investigating novel combinations of semaglutide (GLP-1 receptor agonist) and...
Browse by tag
bottom of page